SCHEMBL23618656

SCHEMBL23618656

CC(C)(C)c1scnc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
XIAP P98170 1/20 0.38
KDM4E B2RXH2 2/20 0.38
SLC22A12 Q96S37 1/20 0.36
IDO1 P14902 2/20 0.36
ALOX15 P16050 1/20 0.35
PDPK1 O15530 1/20 0.35
ADORA2A P29274 2/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
ADORA1 P30542 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CKS1B P61024 1/20 0.34
SKP1 P63208 1/20 0.34
SKP2 Q13309 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
NTRK1 P04629 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2089600 0.75 KDM4E (0.40) KDM4EALOX15PDPK1MAPTADORA1
SCHEMBL926914 0.72 KDM4E (0.55) KDM4EALOX15PDPK1ADORA2ACYP3A4
SCHEMBL543734 0.72 ADORA1 (0.47) KDM4EADORA2AMAPTADORA1ALDH1A1
SCHEMBL18057164 0.71 KDM4E (0.40) KDM4EALOX15PDPK1ADORA2ACYP3A4
SCHEMBL13034536 0.71 KDM4E (0.40) KDM4EALOX15PDPK1ADORA2ACYP3A4
SCHEMBL23072120 0.71 ALDH1A1 (0.50) KDM4EMAPTALDH1A1HSD17B10
SCHEMBL23618660 0.71 KDM4E (0.49) AKT1AKT2KDM4EPDPK1MAPT
SCHEMBL9607536 0.71 L3MBTL1 (0.49) AKT1AKT2XIAPKDM4EMAPT
SCHEMBL11752440 0.70 KDM4E (0.51) XIAPKDM4ESLC22A12MAPTNTRK1
SCHEMBL11753099 0.70 KDM4E (0.44) AKT1AKT2KDM4ESLC22A12ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210205291-A1 NITROGENOUS HETEROCYCLIC AMIDE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL APPLICATION SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210205291-A1 NITROGENOUS HETEROCYCLIC AMIDE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL APPLICATION NNT, NAPRT, NAT1 AKT1 3326/4885AKT2 2720/4885XIAP 4778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.